Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes

Molecular Vision

Volumn 18, Issue , 2012, Pages 1260-1270

  Huang, Tai Qin ^a   Wang, Yiwei ^a   Ebrahem, Quteba ^b   Chen, Yu ^c   Cheng, Cindy ^a   Doughman, Yong Qiu ^c   Watanabe, Michiko ^c   Dunwoodie, Sally L ^d   Yang, Yu Chung ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TOPOTECAN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITED2 GENE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; GENE; GENE DELETION; GENE SILENCING; HYALOID VASCULAR SYSTEM; HYPOXIA INDUCIBLE FACTOR 1ALPHA GENE; LENS DISEASE; MOUSE; NONHUMAN; ORGAN SIZE; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; PHENOTYPE; PRIORITY JOURNAL; TISSUE DIFFERENTIATION; VASCULARIZATION; VEGF GENE;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LENS, CRYSTALLINE; MICE; MICE, KNOCKOUT; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; PROTEIN BINDING; REPRESSOR PROTEINS; SEQUENCE DELETION; TOPOISOMERASE I INHIBITORS; TOPOTECAN; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863314020     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Graw J. Genetics of crystallins: cataract and beyond. Exp Eye Res 2009; 88:173-89. [PMID: 19007775]
2. Eiden LE, Latker C, Zatz M. Retinal toxicity of methylazoxymethanol acetate is developmentally specific. Brain Res 1981; 227:425-8. [PMID: 7260649]
3. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92:5510-4. [PMID: 7539918]
4. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitinproteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997; 272:22642-7. [PMID: 9278421]
5. Ebert BL, Bunn HF. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxiainducible factor 1, an adjacent transcription factor, and p300/ CREB binding protein. Mol Cell Biol 1998; 18:4089-96. [PMID: 9632793]
6. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 1996; 93:12969-73. [PMID: 8917528]
7. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 2000; 20:402-15. [PMID: 10594042]
8. Freedman SJ, Sun ZY, Kung AL, France DS, Wagner G, Eck MJ. Structural basis for negative regulation of hypoxiainducible factor-1alpha by CITED2. Nat Struct Biol 2003; 10:504-12. [PMID: 12778114]
9. Yin Z, Haynie J, Yang X, Han B, Kiatchoosakun S, Restivo J, Yuan S, Prabhakar NR, Herrup K, Conlon RA, Hoit BD, Watanabe M, Yang YC. The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci USA 2002; 99:10488-93. [PMID: 12149478]
10. Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 1999; 13:64-75. [PMID: 9887100]
11. Xu B, Doughman Y, Turakhia M, Jiang W, Landsettle CE, Agani FH, Semenza GL, Watanabe M, Yang YC. Partial rescue of defects in Cited2-deficient embryos by HIF-1alpha heterozygosity. Dev Biol 2007; 301:130-40. [PMID: 17022961]
12. Chen Y, Doughman YQ, Gu S, Jarrell A, Aota S, Cvekl A, Watanabe M, Dunwoodie SL, Johnson RS, van Heyningen V, Kleinjan DA, Beebe DC, Yang YC. Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis. Development 2008; 135:2939-48. [PMID: 18653562]
13. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42. [PMID: 8602242]
14. Rutland CS, Mitchell CA, Nasir M, Konerding MA, Drexler HC. Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter. Mol Vis 2007; 13:47-56. [PMID: 17277743]
15. Garcia CM, Shui YB, Kamath M, DeVillar J, Johnson RS, Gerber HP, Ferrara N, Robinson ML, Beebe DC. The function of VEGF-A in lens development: formation of the hyaloid capillary network and protection against transient nuclear cataracts. Exp Eye Res 2009; 88:270-6. [PMID: 18782574]
16. Shui YB, Arbeit JM, Johnson RS, Beebe DC. HIF-1: an agedependent regulator of lens cell proliferation. Invest Ophthalmol Vis Sci 2008; 49:4961-70. [PMID: 18586877]
17. Reese AB. Persistent hyperplastic primary vitreous. Am J Ophthalmol 1955; 40:317-31. [PMID: 13248898]
18. Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 1997; 124:587-626. [PMID: 9372715]
19. Jain TP. Bilateral persistent hyperplastic primary vitreous. Indian J Ophthalmol 2009; 57:53-4. [PMID: 19075412]
20. Reichel MB, Ali RR, D'Esposito F, Clarke AR, Luthert PJ, Bhattacharya SS, Hunt DM. High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ 1998; 5:156-62. [PMID: 10200460]
21. Thornton JD, Swanson DJ, Mary MN, Pei D, Martin AC, Pounds S, Goldowitz D, Skapek SX. Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the arf tumor suppressor. Invest Ophthalmol Vis Sci 2007; 48:491-9. [PMID: 17251441]
22. Martin AC, Thornton JD, Liu J, Wang X, Zuo J, Jablonski MM, Chaum E, Zindy F, Skapek SX. Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene. Invest Ophthalmol Vis Sci 2004; 45:3387-96. [PMID: 15452040]
23. Ohlmann AV, Adamek E, Ohlmann A, Lutjen-Drecoll E. Norrie gene product is necessary for regression of hyaloid vessels. Invest Ophthalmol Vis Sci 2004; 45:2384-90. [PMID: 15223821]
24. Saint-Geniez M, D'Amore PA. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol 2004; 48:1045-58. [PMID: 15558494]
25. Preis JI, Wise N, Solloway MJ, Harvey RP, Sparrow DB, Dunwoodie SL. Generation of conditional Cited2 null alleles. Genesis 2006; 44:579-83. [PMID: 17133411]
26. Ashery-Padan R, Marquardt T, Zhou X, Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev 2000; 14:2701-11. [PMID: 11069887]
27. Bassnett S, McNulty R. The effect of elevated intraocular oxygen on organelle degradation in the embryonic chicken lens. J Exp Biol 2003; 206:4353-61. [PMID: 14581604]
28. Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 2002; 62:4316-24. [PMID: 12154035]
29. Bamforth SD, Braganca J, Eloranta JJ, Murdoch JN, Marques FI, Kranc KR, Farza H, Henderson DJ, Hurst HC, Bhattacharya S. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet 2001; 29:469-74. [PMID: 11694877]
30. Bamforth SD, Braganca J, Farthing CR, Schneider JE, Broadbent C, Michell AC, Clarke K, Neubauer S, Norris D, Brown NA, Anderson RH, Bhattacharya S. Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet 2004; 36:1189-96. [PMID: 15475956]
31. Withington SL, Scott AN, Saunders DN, Lopes Floro K, Preis JI, Michalicek J, Maclean K, Sparrow DB, Barbera JP, Dunwoodie SL. Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta. Dev Biol 2006; 294:67-82. [PMID: 16579983]
32. Xu B, Qu X, Gu S, Doughman YQ, Watanabe M, Dunwoodie SL, Yang YC. Cited2 is required for fetal lung maturation. Dev Biol 2008; 317:95-105. [PMID: 18358466]
33. Qu X, Lam E, Doughman YQ, Chen Y, Chou YT, Lam M, Turakhia M, Dunwoodie SL, Watanabe M, Xu B, Duncan SA, Yang YC. Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J 2007; 26:4445-56. [PMID: 17932483]
34. Buaas FW, Val P, Swain A. The transcription co-factor CITED2 functions during sex determination and early gonad development. Hum Mol Genet 2009; 18:2989-3001. [PMID: 19457926]
35. Chen Y, Haviernik P, Bunting KD, Yang YC. Cited2 is required for normal hematopoiesis in the murine fetal liver. Blood 2007; 110:2889-98. [PMID: 17644732]
36. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32. [PMID: 1372863]
37. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, Yuce A, Fujisawa H, Hermans B, Shani M, Jansen S, Hicklin D, Anderson DJ, Gardiner T, Hammes HP, Moons L, Dewerchin M, Collen D, Carmeliet P, D'Amore PA. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109:327-36. [PMID: 11827992]
38. Mitchell CA, Rutland CS, Walker M, Nasir M, Foss AJ, Stewart C, Gerhardt H, Konerding MA, Risau W, Drexler HC. Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens. Angiogenesis 2006; 9:209-24. [PMID: 17109192]
39. Chou YT, Wang H, Chen Y, Danielpour D, Yang YC. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene 2006; 25:5547-60. [PMID: 16619037]
40. Lopes Floro K, Artap ST, Preis JI, Fatkin D, Chapman G, Furtado MB, Harvey RP, Hamada H, Sparrow DB, Dunwoodie SL. Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. Hum Mol Genet 2011; 20:1097-110. [PMID: 21224256]
41. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, Johnson RS, Suematsu M, Tsubota K, Ishida S, Goda N, Suda T, Okano H. von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 2010; 137:1563-71. [PMID: 20388654]
42. Kurihara T, Westenskow PD, Krohne TU, Aguilar E, Johnson RS, Friedlander M. Astrocyte pVHL and HIF-alpha isoforms are required for embryonic-to-adult vascular transition in the eye. J Cell Biol 2011; 195:689-701. [PMID: 22084310]
43. Kranc KR, Schepers H, Rodrigues NP, Bamforth S, Villadsen E, Ferry H, Bouriez-Jones T, Sigvardsson M, Bhattacharya S, Jacobsen SE, Enver T. Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell 2009; 5:659-65. [PMID: 19951693]
44. Kranc KR, Bamforth SD, Braganca J, Norbury C, van Lohuizen M, Bhattacharya S. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Mol Cell Biol 2003; 23:7658-66. [PMID: 14560011]
45. Mallipatna AC, Dimaras H, Chan HSL, Heon E, Gallie BL. Periocular Topotecan for Intraocular Retinoblastoma. Arch Ophthalmol 2011; 129:738-45. [PMID: 21670340]